Selection from HEOR Bibliography

IMS logo
Search criteria
Country: Canada
 
Real-world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real-world study
Authors: Jonathan Gladstone 1, Sameer Chhibber 2, Jagdeep Minhas 3, Calum S Neish 3, G Sarah Power 3, Zhiyi Lan 3, Driss Rochdi 4, Jessica Lanthier-Martel 4, Natacha Bastien 4
Affiliations: 1Neurology, Cleveland Clinic Canada, Toronto, Ontario, Canada. 2Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada. 3Real-world Solutions, IQVIA, Kirkland, Québec, Canada. 4Neuroscience, Novartis Pharmaceuticals Canada Inc., Dorval, Québec, Canada.
Publications: 
Headache The Journal of Head and Face Pain PMID: 34807454 DOI: 10.1111/head.14218
Document Types: , Article
Countries: , Canada
Abstract: https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14218
Condition Year Language Analysis type
, Health status & patient reported outcomes 2022 English , Clinical setting: Primary care, direct to patient research
 
 
Real-world 12-month Retention on Secukinumab Among Axial Spondyloarthritis Patients within the Canadaian Spondyloarthritis (CanSpA) Research Network
Authors: Dr. Robert Inman, Dr. Denis Choquette, Dr. Majed Khraishi, Dr. Dafna Gladman, Shamiza Hussein, Drew Neish, Patrick Leclerc
Affiliations: Robert Inman (Toronto Western Hospital, Toronto); Denis Choquette (Institut de Rhumatologie de Montréal, Montréal); Majed Khraishi (Department of Medicine, Memorial University of Newfoundland, St. John's); Dafna Gladman (Krembil Research Institute, Toronto Western Hospital, Toronto); Shamiza Hussein (Novartis, Montreal); Drew Neish (IQVIA, Montreal); Patrick Leclerc (Novartis Canada, Montreal)
Publications: 
Document Types: , Poster
Countries: , Canada
Abstract: https://asm.rheum.ca/wp-content/uploads/2022/01/2022-Poster-Presentations.pdf
Condition Year Language Analysis type
, Clinical practice 2022 English , Clinical setting: hospital
 
 
Concomitant Medication Use in the Treatment Journey of Pulmonary Arterial Hypertension Patients: A Canadian Retrospective Claims Analysis
Authors: Essam Ibrahim1, Assem Al-Akabawi1, Moses Dawodu1, Juejing Ling2, Irene Wang2, Brad Millson3
Affiliations: 1Janssen Canada Inc, Toronto, ON, Canada; 2IQVIA Solutions Canada Inc., Mississauga, ON, Canada; 3IQVIA Solutions Canada Inc., Kanata, ON, Canada
Publications: 
Document Types: , Poster
Countries: , Canada
Condition Year Language Analysis type
, Endocrinology 2022 English , Clinical setting: hospital, Clinical setting: Primary care, direct to patient research, Observational study
 
 
Real-World Drug Retention and Initiation of Combination Drug Therapy for Patients with Pulmonary Arterial Hypertension in Canada: A Retrospective Prescription Claims Database Study
Authors: Essam Ibrahim1, Assem Al-Akabawi1, Moses Dawodu1, Juejing Ling2, Jillian Murray2, Brad Millson3
Affiliations: 1Janssen Canada Inc, Toronto, ON, Canada; 2IQVIA Solutions Canada Inc., Mississauga, ON, Canada; 3IQVIA Solutions Canada Inc., Kanata, ON, Canada
Publications: 
IQVIA Canadian Private Drug Plan (PDP) databases
Document Types: , Poster
Countries: , Canada
Condition Year Language Analysis type
2022 English , direct to patient research
 
 
A real-world, observational study of erenumab for migraine prevention in Canadian patients
Authors: Werner J Becker 1, Sian Spacey 2, Elizabeth Leroux 3, Rose Giammarco 4, Jonathan Gladstone 5, Suzanne Christie 6, Arash Akaberi 7, G Sarah Power 8, Jagdeep K Minhas 9, Johanna Mancini 7, Driss Rochdi 10, Ayca Filiz 10, Natacha Bastien 10
Affiliations: 1Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada. 2Division of Neurology, University of British Columbia, Vancouver, British Columbia, Canada. 3Brunswick Medical Center, Montreal, Quebec, Canada. 4Hamilton Headache Clinic, Hamilton, Ontario, Canada. 5Gladstone Headache Clinic, Toronto, Ontario, Canada. 6Ottawa Headache Centre Inc., Ottawa, Ontario, Canada. 7IQVIA Solutions Canada Inc., Montreal, Quebec, Canada. 8IQVIA Solutions Canada Inc., Mississauga, Ontario, Canada. 9IQVIA Solutions Canada Inc., Ottawa, Ontario, Canada. 10Novartis Canada, Dorval, Quebec, Canada.
Publications: 
Headache. 2022 Apr;62(4):522-529. doi: 10.1111/head.14291. Epub 2022 Apr 10. PMID: 35403223.
Document Types: , Article
Countries: , Canada
Abstract: https://pubmed.ncbi.nlm.nih.gov/35403223/
Condition Year Language Analysis type
, Neurological disorders 2022 English , Observational study
 
 
Characterisation of Pulmonary Arterial Hypertension (PAH) Patients Initiating a New PAH Specific Therapy in the Context of Age: Insights from EXPOSURE
Authors: P. Escribano (1), S. Gaine (2), P. Biedermann (3), A. Muller (3), M. Valge (4), T. Lange (5), S. Söderberg (6)
Affiliations: 1 Pulmonary Hypertension Unit, Cardiology Department, CIBERCV, Hospital 12 de Octubre, Madrid, Spain 2 National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland 3 Actelion Pharmaceuticals Ltd, Allschwil, Switzerland 4 StatFinn Estonia OÜ, Tartu, Estonia (now IQVIA) 5 University Medical Center Regensburg, Regensburg, Germany 6 Department of Public Health and Clinical Medicine, Cardiology and Heart Centre, Umeå University, Umeå, Sweden
Publications: 
JO - The Journal of Heart and Lung Transplantation VL - 40 IS - 4, Supplement SP - S109 PY - 2021 DA - 2021/04/01/ SN - 1053-2498
Document Types: , Abstract
Countries: , Canada, Europe
Abstract: https://www.jhltonline.org/article/S1053-2498(21)00365-X/fulltext#articleInformation
Condition Year Language Analysis type
, Cardiovascular disease 2021 English , Epidemiological study, Observational study
 
 
Risk Factors and Medical Resource Utilization of Respiratory Syncytial Virus, Human Metapneumovirus and Influenza Related Hospitalizations in Adults – A Global Study During the 2017-2019 Epidemic Seasons (Hospitalized Acute Respiratory Tract Infection [HARTI] Study)
Authors: Ann R Falsey, Edward E Walsh, Stacey House, Yannick Vandenijck, Xiaohui Ren, Sofia Keim, Diye Kang, Pascale Peeters, James Witek, Gabriela Ispas
Affiliations: University Of Rochester School Of Medicine and Rochester Regional Health, Rochester, NY, United States; Washington University School of Medicine, St Louis, MO, United States; Janssen Infectious Diseases, Beerse, Belgium; IQVIA Real-World Solutions, Courbevoie, France; Janssen Research & Development, LLC, Titusville, NJ, United States
Publications: 
Document Types: , Article
Countries: , Argentina, Australia, Brazil, Canada, France, Germany, Japan, Korea, Malaysia, Mexico, South Africa, USA
Abstract: https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofab491/6381446
Condition Year Language Analysis type
, Infectious disease 2021 English , Burden of illness, Clinical setting: hospital, Epidemiological study, Observational study, Patient questionnaire, Prospective study
 
 
Understanding the COVID Impact on Healthcare System in Canada
Authors: Juejing Ling, Scott Shi, Marc Lapierre, HuijuanYang, Brad Millson
Affiliations: Juejing Ling IQVIA, Scott Shi IQVIA, Marc Lapierre IQVIA, HuijuanYang IQVIA, Brad Millson IQVIA
Publications: 
2021 CADTH Symposium Confrence, November 2, 3 and 4, 2021
Document Types: , Poster
Countries: , Canada
Condition Year Language Analysis type
, COVID-19 2021 English , Clinical setting: Primary care, Economic evaluation
 
 
Prescribing patterns among in-person vs virtual primary care visits pre-and post-COVID-19 in Ontario, Canada
Authors: Muratov S, Neish D, Ellis K, Wang I, Yang H, Bhattacharjee P, Barot P, Kukaswadia A
Affiliations: Muratov S, Neish D, Ellis K, Wang I, Yang H, Bhattacharjee P, Barot P, Kukaswadia A - all IQVIA authors
Publications: 
CAPT 2021 Confrence, October 25-27, 2021
Document Types: , Poster
Countries: , Canada
Condition Year Language Analysis type
, COVID-19 2021 English , Clinical setting: Primary care, Public Health, Survey research
 
 
Real-world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real-world study
Authors: Jonathan Gladstone 1, Sameer Chhibber 2, Jagdeep Minhas 3, Calum S Neish 3, G Sarah Power 3, Zhiyi Lan 3, Driss Rochdi 4, Jessica Lanthier-Martel 4, Natacha Bastien 4
Affiliations: 1Neurology, Cleveland Clinic Canada, Toronto, Ontario, Canada. 2Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada. 3Real-world Solutions, IQVIA, Kirkland, Québec, Canada. 4Neuroscience, Novartis Pharmaceuticals Canada Inc., Dorval, Québec, Canada.
Publications: 
PMID: 34807454 DOI: 10.1111/head.14218
Document Types: , Article, Book chapter
Countries: , Canada
Abstract: https://pubmed.ncbi.nlm.nih.gov/34807454/
Condition Year Language Analysis type
, Miscellaneous 2021 English , direct to patient research, Retrospective cohort analysis
 
 
Real-world treatment patterns, healthcare resource use and clinical outcomes of patients receiving second line therapy for advanced or metastatic gastric cancer
Authors: Gomez-Ulloa D1, Amonkar M2, Kothari S3, Cheung WY4, Chau I5, Zalcberg J6, Lara N1, Falcone A7
Affiliations: 1 IQVIA, Barcelona, Spain 2 Merck & Co., Inc., North Wales, PA, US 3 Merck & Co., Inc., Kenilworth, NJ, US 4 British Columbia Cancer Agency, Vancouver, BC, Canada 5 Royal Marsden Hospital, London, UK 6 Alfred Health, Melbourne, Australia 7 University of Pisa, Pisa, Italy
Publications: 
BMC Gastroenterology
BMC Gastroenterology volume 20, Article number: 133 (2020)
Document Types: , Article
Countries: , Australia, Canada, Italy, UK
Abstract: https://doi.org/10.1186/s12876-020-01232-z
Condition Year Language Analysis type
, Oncology 2020 English , Retrospective cohort analysis
 
 
Patient preferences, treatment satisfaction, and quality of life in newly diagnosed and relapsed/refractory multiple myeloma patients receiving injectable-containing or fully oral therapies: the EASEMENT study
Authors: Neil Rabin1, Rami Kotb2, Athanasios Zomas3, Alonso Fernandez-Nistal3, Rocco D’Ambrosio3, Nawal Bent-Ennakhil3, Montserrat Roset4, Ombretta Annibali5
Affiliations: 1 University College London Hospitals, London, and North Middlesex University Hospital, UK; 2 CancerCare Manitoba, Winnipeg, Manitoba, Canada; 3 Takeda Pharmaceuticals International AG, Zurich, Switzerland; 4 IQVIA, Barcelona, Spain; 5 Università Campus Bio-Medico di Roma, Rome, Italy
Publications: 
COMy (the 6th World Congress on Controversies in Multiple Myeloma), Virtual congress, 3-4 October 2020
Document Types: , Poster
Countries: , Canada, Italy, UK
Condition Year Language Analysis type
, Hematology, Oncology 2020 English , Population Based Study
 
 
Quantifying the burden of the treatment-resistant depression in Ontario: Shredding light on an inportant mental health issue
Authors: Brad Millson, G Sarah Power, Dr. Roger S. McIntyre
Affiliations: Brad Millson, G Sarah Power, IQVIA RWE team
Publications: 
CADTH 2020
Document Types: , Article
Countries: , Canada
Abstract: hhttps://www.sciencedirect.com/science/article/pii/S0165032720324903
Condition Year Language Analysis type
, Health status & patient reported outcomes, Mental health 2020 English , Retrospective cohort analysis
 
 
A Retrospective Observational Cohort study to Assess the Prevalence of Diabetic Kidney Disease Among Type 2 Diabetes Patients in Ontario, Canada
Authors: Wally Rapattoni, David Zante, Ali Tehrani, Varun Myageri, Shane Golden, Brad Millson, Sheldon W. Tobe, Jennifer B. Rose
Affiliations: Ali Tehrai, Varun Myageri, shane Golden, Brad Millson
Publications: 
ERA - EDRA Virtual Congress June 6-9 2020
Document Types: , Poster
Countries: , Canada
Abstract: https://academic.oup.com/ndt/article/35/Supplement_3/gfaa142.P0775/5853053
Condition Year Language Analysis type
, Diabetes, Public Health 2020 English , Clinical setting: hospital, Clinical setting: Primary care, Cost analysis, direct-to-patient research, Observational study, Retrospective cohort analysis
 
 
Investigation of factors considered in the health technology assessment conducted by regulatory authority in eight countries
Authors: Akira Yuasa 1, Naohiro Yonemoto 1, Sven Demiya 2, Chihiro Foellscher 2, Shunya Ikeda 3 (rwesheorj 2)
Affiliations: 1) Pfizer Japan Inc., Tokyo, Japan 2) IQVIA Solutions Japan, Tokyo, Japan 3) Graduate School of Medicine, International University of Health and Welfare, Tokyo, Japan
Publications: 
ISPOR 2020 Conference
Document Types: , Abstract
Countries: , Australia, Canada, France, Germany, Italy, Japan, Spain, UK
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/intl2020-3182/101019
Condition Year Language Analysis type
2020 English
 
 
GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data.
Authors: Divino V, Boye KS, Lebrec J, DeKoven M, Norrbacka K
Affiliations: IQVIA, Eli Lilly
Publications: 
Journal. Diabetes Ther. 2019 Jun;10(3):1067-1088.
Document Types: , Article
Countries: , Belgium, Canada, France, Germany, Italy, Netherlands
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31028689
Condition Year Language Analysis type
, Diabetes 2019 English , Retrospective database analysis
 
 
A population-based analysis of anti-diabetic medications in four Canadian provinces: secular trends and prescribing patterns
Authors: Secrest MH, Azoulay L, Dahl M, Clemens KK, Durand M, Hu N, Targownik L, Turin TC, Dormuth CR, and Filion KB
Affiliations: IQVIA, Cambridge, MA
Publications: 
Pharmacoepidemiology & Drug Safety (in press)
Document Types: , Article, In press/to be published
Countries: , Canada
Condition Year Language Analysis type
, Diabetes, Drug Utlization Study 2019 English , Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis
 
 
The Pharmacoepidemiology of Anti-Depressant Prescribing Trends in Canadian Children from 2012 to 2016
Authors: Aysha Lukmanji1BA&Sc, Tamara Pringsheim2,3MD, Andrew G. Bulloch1,3PhD, David G Stewart1, Parco Chan1, Ali Tehrani1, Scott B. Patten1,3,4MD PhD
Affiliations: 1Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW Calgary, Alberta T2N 4Z6, Canada 2 Department of Clinical Neurosciences 3 Mathison Center for Research & Education, Hotchkiss Brain Institute, University of Calgary 4Cuthbertson & Fischer Chair in Pediatric Mental Health, University of Calgary. 5 IQVIA Canada
Publications: 
J Child Adolesc Psychopharmacol. 2019 Jul 29. doi: 10.1089/cap.2019.0018
Document Types: , Article
Countries: , Canada
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31355670
Condition Year Language Analysis type
2019 English
 
 
PRODUCTIVITY LOSS IN THE FIRST YEAR AFTER A CARDIOVASCULAR EVENT IN CANADA: A CROSS SECTIONAL STUDY OF WORKING ADULTS
Authors: A. Shekhar Pandey, B.Sc., MD, FRCPC, ABIM, CBNC;1 Milan Gupta, MD, FRCPC, FACC;1 Theodore Wein, MD, FRCPC, FAHA;2 Aren Fischer, MSc;3 Johanna Mancini, BSc, MSc, PhD;3 Eduard Sidelnikov, MD, PhD;4 Raina Rogoza, MSc;5 Louisa Pericleous, MSc, PhD.5
Affiliations: 1Department of Medicine, McMaster University, Hamilton, ON, Canada; 2Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada; 3IQVIA, Mississauga, ON, Canada; 4AMGEN, Europe GmbH, Rotkreuz, Switzerland; 5AMGEN; Mississauga, ON, Canada.
Publications: 
Document Types: , Poster
Countries: , Canada
Condition Year Language Analysis type
, Cardiovascular disease 2019 English
 
 
Trends in Psychotropic Medication Use for Canadian Children and Youth with ASD from 2010 to 2016: A Pharmacoepidemiologic Study
Authors: McMorris, C.A.1, Patten, S.2, Stewart, D.3, Tehrani, A.3 & Pringsheim, T.2
Affiliations: 1 Werklund School of Education, University of Calgary (Calgary, AB Canada) 2 Cumming School of Medicine, University of Calgary (Calgary, AB Canada)
Publications: 
Document Types: , Poster
Countries: , Canada
Condition Year Language Analysis type
, Mental health 2019 English , Database Study
 
 
Prescriptions for Alpha Agonists and Antipsychotics in Children and Youth with Tic Disorders: A Pharmacoepidemiologic Study
Authors: Nicholas Cothros1, Davide Martino1, Carly McMorris2,3, David Stewart4, Ali Tehrani4 & Tamara Pringsheim1,5,6*
Affiliations: 1Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary and Hotchkiss Brain Institute, Foothills Hospital, Calgary, AB, CA, 2Werklund School of Education, Alberta Childrens Hospital Research Institute (ACHRI), University of Calgary, Calgary, AB, CA, 3The Owerko Centre, Child Development Centre (CDC), Calgary, AB, CA, 4IQVIA, Kanata, ON, CA, 5Department of Psychiatry, Cumming School of Medicine, University of Calgary, Foothills Hospital, Calgary, AB, CA, 6Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, AB, CA
Publications: 
Tremor Other Hyperkinet Mov (N Y)v.9; 2019
Document Types: , Article
Countries: , Canada
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691607/
Condition Year Language Analysis type
, Mental health 2019 English , Survey research
 
 
LANDSCAPE TRANSFORMATION: pCPA CHANGES AND IMPACT TO MARKET ACCESS IN CANADA RESULTS FROM AN OBSERVATIONAL CROSS-SECTIONAL STUDY
Authors: Minhas, Jagdeep, M.Biotech1; Iqbal-Khan, Sarah, MBA2; Laforty, Callahan, MSc2; Ling, Juejing, MSc2; Shi, Scott, PharmD2; Millson, Brad, MBS1
Affiliations: 1Health Access and Outcomes, IQVIA, 535 Legget Drive, Kanata, ON, K2K 3B8; 2Health Access and Outcomes, IQVIA, 6700 Century Avenue, Mississauga, ON, L5N 6A4
Publications: 
CADTH Symposium 2019, Edmonton, AB, April 14-16, 2019
Document Types: , Poster
Countries: , Canada
Condition Year Language Analysis type
2019 English
 
 
Anti-VEGF persistence and switching in nAMD: real world analysis from a Canadian claims database
Authors: Tina Maio-Twofoot 1, Alexandros Sagkriotis 2, Atif Kukaswadia 3, Franois Lebeau 1, Valerie Gregory 1
Affiliations: 1 Novartis Pharmaceuticals Canada Inc., 2 Novartis Pharma AG; 3 IQVIA
Publications: 
Document Types: , Poster
Countries: , Canada
Condition Year Language Analysis type
, Ophthalmology 2019 English , Longitudinal study, Observational study, Retrospective database analysis
 
 
Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada
Authors: Sean Wharton1, Aiden Liu2, Arash Pakseresht2, Emil N?rtoft3, Christiane L. Haase3, Johanna Mancini4, G. Sarah Power5, Sarah Vanderlelie1, and Rebecca A. G. Christensen1
Affiliations: 1 Wharton Medical Clinic, Burlington, Canada. Correspondence: Sean Wharton (wharton@whartonmedicalclinic.com) 2 Novo Nordisk Canada Inc., Mississauga, Canada 3 Novo Nordisk A/S, S?borg, Denmark 4 IQVIA, Kirkland, Canada 5 IQVIA, Mississauga, Canada.
Publications: 
Obesity (Silver Spring). 2019 Jun;27(6):917-924. doi: 10.1002/oby.22462. Epub 2019 May 7.
Document Types: , Article
Countries: , Canada, Nordic
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31062937
Condition Year Language Analysis type
, Obesity 2019 English
 
 
Reduction in the Utilization of Prednisone or Methotrexate in Canadian Claims Data Following Initiation of Etanercept in Pediatric Patients with Juvenile Idiopathic Arthritis
Authors: Majed M M Khraishi1, Brad Millson2, John Woolcott3, Lisa Marshall4 and Heather Jones4
Affiliations: 1Memorial University of Newfoundland, St John's, NF, Canada, 2IQVIA, Kanata, ON, Canada, 3Global Outcomes & Evidence, Pfizer, Collegeville, PA, 4Pfizer, Collegeville, PA
Publications: 
Annals of the Rheumatic Diseases 2018;77:494.
Document Types: , Article
Countries: , Canada
Abstract: https://acrabstracts.org/abstract/reduction-in-the-utilization-of-prednisone-and-or-methotrexate-following-the-initiation-of-etanercept-in-pediatric-patients/
Condition Year Language Analysis type
, Pediatrics, Rheumatology 2019 English , Longitudinal study, Retrospective database analysis
 
 
Real-world utilization of methotrexate or prednisone co-therapy with etanercept among Canadian patients with rheumatoid arthritis: a retrospective cohort study
Authors: Majed Khraishi, Jelena Ivanovic, Yvonne Zhang, Brad Millson, Marie-Josee Brabant, John Woolcott, Heather Jones & Cinzia Curiale
Affiliations: 
Publications: 
Journal of Current Medical Research and Opinion, Accepted author version posted online: 25 Jun 2019, Published online: 10 Jul 2019
Document Types: , Article
Countries: , Canada
Abstract: ?https://doi.org/10.1080/03007995.2019.1636543
Condition Year Language Analysis type
, Rheumatology 2019 English , Retrospective cohort analysis
 
 
AN EARLY LOOK AT THE SECOND DOSE COMPLETION OF THE RECOMBINANT ZOSTER VACCINE (RZV) IN CANADIAN ADULTS ? A RETROSPECTIVE ANALYSIS
Authors: Ashleigh McGirr1, Tara Bourgoin2, Michael Wortzman1, Brad Millson2, Shelly McNeil3
Affiliations: 1GSK, Mississauga, Canada, 2IQVIA, Ot tawa, Canada, 3Canadian Center for Vaccinology, IWK Heal th Centre and Nova Scotia Health Authority, Dalhousie University
Publications: 
The CIRN Annual Meeting, 20 & 21 November 2019 - Toronto, Canada
Document Types: , Poster
Countries: , Canada
Abstract: https://gsk.envisionpharma.com/dv_gsk_bio/
Condition Year Language Analysis type
, Immunology and Vaccination 2019 English , Retrospective database analysis
 
 
Patient characteristics and treatment patterns in multiple myeloma by treatment administration route and disease status: EASEMENT observational study
Authors: Rabin N1, Kotb R2, Zomas A3, Gonzalez F3, Fernandez-Nistal A3, D’Ambrosio R3, Bent-Ennakhil N3, Roset M4, Annibali O5
Affiliations: 1 University College Hospital, London, UK 2 Cancer Care Manitoba, Canada 3 Takeda Pharmaceuticals International AG, Switzerland 4 IQVIA, Barcelona, Spain 5 Università Campus Bio-Medico di Roma, Italy
Publications: 
IMW, Boston, US, 12-15 September 2019
Document Types: , Poster
Countries: , Canada, Italy, UK
Abstract: https://doi.org/10.1016/j.clml.2019.09.456
Condition Year Language Analysis type
, Clinical practice, Hematology 2019 English , Epidemiological study, Observational study
 
 
The clinical and cost impact of switching to fingolimod versus other first line injectable disease-modifying therapies in patients with relapsing multiple sclerosis
Authors: Freedman MS1, Duquette P2, Grand'Maison F3, Lee L4, Vorobeychik G5, Lara N6, Khurana V7, Nakhaipour HR8, Schecter R8, Haddad P8
Affiliations: 1 University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada 2 Notre Dame Hospital, Université de Montréal, Montreal, Quebec , Canada 3 Neuro-Rive Sud Clinic , Greenfield Park , Quebec , Canada 4 Sunnybrook Health Sciences Centre , University of Toronto , Toronto , Ontario , Canada 5 Fraser Health Multiple Sclerosis Clinic Burnaby Hospital , Burnaby , British Columbia , Canada 6 IQVIA , Barcelona , Spain 7 Novartis Healthcare Private Limited , Hyderabad , India 8 Novartis Pharmaceuticals Canada Inc., Dorval, Quebec, Canada
Publications: 
Curr Med Res Opin. 2019 May;35(5):767-776
Document Types: , Article
Countries: , Canada
Abstract: doi: 10.1080/03007995.2019.1565818. Epub 2019 Jan 21.
Condition Year Language Analysis type
, Neurological disorders 2019 English , Burden of illness, Retrospective Field Study
 
 
Real-world treatment patterns and clinical outcomes in patients receiving second-line (2L) treatment for advanced or metastatic gastric cancer (GC)
Authors: Amonkar M1, Gomez-Ulloa D2, Smita Kothari1, Cheung WY3, Chau I4, Zalcberg JR5, Lara N2, Falcone A6
Affiliations: 1 Merck & Co., Inc., Kenilworth, NJ, USA 2 IQVIA, Barcelona, Spain 3 British Columbia Cancer Agency, Vancouver, BC, Canada 4 Royal Marsden Hospital, London, UK 5 Alfred Health, Melbourne, Australia 6 University of Pisa, Pisa, Italy
Publications: 
BMC Gastroenterology volume 20, Article number: 133 (2020)
Document Types: , Poster
Countries: , Australia, Canada, Italy, UK
Condition Year Language Analysis type
, Oncology 2019 English , Retrospective cohort analysis
 
 
Severe, eosinophilic asthma in primary care in Canada: a longitudinal study of the clinical burden and economic impact based on linked electronic medical record data.
Authors: Husereau D1, Goodfield J2, Leigh R3, Borrelli R2, Cloutier M2, Gendron A4,5.
Affiliations: 1Department of Epidemiology and Community Medicine, School of Epidemiology and Public Health, University of Ottawa, Room 101, 600 Peter Morand Crescent, Ottawa, ON K1G 5Z3 Canada 2IQVIA, Mississauga, ON Canada 3Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB Canada 4AstraZeneca Canada Inc, Mississauga, ON Canada 5Department of Medicine, University of Montreal, Montreal, QC Canada
Publications: 
Allergy Asthma Clin Immunol. 2018 Apr 24;14:15.
Document Types: , Article
Countries: , Canada
Condition Year Language Analysis type
2018 English , Retrospective database analysis
 
 
Clinical characteristics of Glioblastoma Multiforme (GBM) Patients Who Reached 400 Days Post Diagnostic from a Retrospective Real-World Data
Authors:  Mitrofan L.M.1,Krukas-Hampel M.R.2, Mendoza L.A.3
Affiliations: 1 IQVIA, Paris, FR; 2IQVIA New York, US; 3IQVIA, Prague, CZ
Publications: 
ESMO 2018
Document Types: , Poster
Countries: , Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK
Condition Year Language Analysis type
, Oncology 2018 English
 
 
Clinical Characteristics of 3,030 Glioblastoma Multiforme (GBM) Patients in High, Upper Middle and Lower Middle Economic Regions Based on Real-World Data (RWD)
Authors:  Mitrofan L1 , M.R. Krukas-Hampel M.R2 , L.A. Mendoza L.A3
Affiliations: IQVIA, Paris, FR; IQVIA New York, US; IQVIA, Prague, CZ
Publications: 
ESMO 2018
Document Types: , Poster
Countries: , Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK
Condition Year Language Analysis type
, Oncology 2018 English
 
 
Impact of the Adalimumab Patient Support Program's Care Coach Calls on Persistence and Adherence in Canada: An Observational Retrospective Cohort Study
Authors: John K. Marshall MD, MSc, FRCPC 1, Louis Bessette MD, MSc, FRCPC 2, Carter Thorne MD, FRCPC 3, Neil H. Shear MD, FRCPC 4, 5, Gerald Lebovic PhD 6, 7, Sebastien K. Gerega MBA 8, Brad Millson MBS 8, Driss Oraichi PhD 8, Tania Gaetano B.Comm, MIS 9, Sandra Gazel MBA, MSc 9, Martin G. Latour PhD 9, Marie-Claude Laliberté PhD 9
Affiliations: 1 Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada 2 Department of Medicine, Laval University, Quebec City, Quebec, Canada 3 Southlake Regional Health Centre, Newmarket, Ontario, Canada 4 Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada 5 Department of Medicine, Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada 6 Applied Health Research Centre, St. Michael's Hospital, Toronto, Ontario, Canada 7 Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada 8 QuintilesIMS, Kirkland, Quebec, Canada 9 AbbVie Corporation, St. Laurent, Quebec, Canada
Publications: 
Clinical Therapeutics, Volume 40, Issue 3 pages 415-429.e6
Document Types: 
Countries: , Canada
Abstract: https://www.sciencedirect.com/science/article/pii/S014929181830050X?via%3Dihub#!
Condition Year Language Analysis type
, Miscellaneous 2018 English , Observational study, Retrospective cohort analysis
 
 
Impact of the Adalimumab Patient Support Program on Clinical Outcomes in Ankylosing Spondylitis: Results from the COMPANION Study
Authors: Louis BessetteEmail author, Gerald Lebovic, Brad Millson, Katia Charland, Krishna Donepudi, Tania Gaetano, Valencia Remple, Martin G. Latour, Sandra Gazel, Marie-Claude Laliberté, Carter Thorne
Affiliations: 1. Department of Medicine, Laval University, Quebec, Canada 2. Applied Health Research Centre, St. Michael’s Hospital, Toronto, Canada 3. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada 4. QuintilesIMS, Quebec, Canada 5. AbbVie Corporation, Quebec, Canada 6. Southlake Regional Health Centre, Newmarket, Canada
Publications: 
Rheumatology and Therapy, June 2018, Volume 5, Issue 1, pages 75-85
Document Types: 
Countries: , Canada
Abstract: https://link.springer.com/article/10.1007/s40744-018-0109-3
Condition Year Language Analysis type
, Miscellaneous 2018 English , Longitudinal study
 
 
Canada's Study of Adherence Outcomes in Patients Receiving Adalimumab: 3-year Results From the COMPANION Study
Authors:  John K. Marshall MD, MSc, FRCPC 1, Louis Bessette MD, MSc, FRCPC 2, Neil H. Shear MD, FRCPC 3, 4, Gerald Lebovic PhD 5, 6, Jennifer Glass PhD 7, Brad Millson MBS 7, Tania Gaetano BComm, MIS 8, Sandra Gazel MBA, MSc 8, Martin G. Latour PhD 8, Marie-Claude Laliberté PhD 8, J. Carter Thorne MD, FRCP 5, 6
Affiliations: 1 Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada 2 Department of Medicine, Laval University, Quebec City, Quebec, Canada 3 Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada 4 Department of Medicine, Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada 5 Applied Health Research Centre, St. Michael's Hospital, Toronto, Ontario, Canada 6 Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada 7 QuintilesIMS, Health Access and Outcomes, Kirkland, Quebec, Canada 8 AbbVie Corporation, St. Laurent, Quebec, Canada
Publications: 
Document Types: 
Countries: , Canada
Abstract: https://www.sciencedirect.com/science/article/pii/S014929181830184X?via%3Dihub
Condition Year Language Analysis type
, Miscellaneous 2018 English , Longitudinal study, Retrospective cohort analysis
 
 
Assessing the Benefits of Co-pay Card Usage Among Diabetic Patients in Canada
Authors: Jing Guo 1, Christian Silva 1, Chris Stewart 1, Andrew Leung 1, Behlool Khan 2, Johanna Mancini 2
Affiliations: 1 Department of Mechanical and Industrial Engineering, University of Toronto 2 IQVIA
Publications: 
Document Types: , Poster
Countries: , Canada
Abstract: http://imsbrogancapabilities.com/pdf/rwe/frontiers-2018-final-poster-for-presentation.pdf
Condition Year Language Analysis type
, Diabetes 2018 English , Retrospective cohort analysis
 
 
Cost-Effectiveness Analysis of Brodalumab in Moderate-to-Severe Plaque Psoriasis in Canada
Authors: Xue, W. 1, Gray, E. 1, Khoudigian-Sinani, S. 2, Barbeau, M. 3, Frieder, D. 3
Affiliations: 1 IQVIA, London, UK, 2 IQVIA Mississauga, ON, Canada, 3 Valeant Canada LP, Laval QC, Canada
Publications: 
ISPOR 23rd Annual International Meeting, May 19-23, 2018, Baltimore, MD, USA
Document Types: , Poster
Countries: , Canada
Abstract: http://imsbrogancapabilities.com/pdf/rwe/valeantbrodalumab-cem-poster-ispor-final.pdf
Condition Year Language Analysis type
, Dermatology 2018 English , Database Study
 
 
Efficacy of Brodalumab in the Treatment of Moderate-to-Severe Psoriasis: A Network Meta-Analysis
Authors: Xue, W. 1, Saharia, P. 2, Gray, E. 1, Khoudigian-Sinani, S. 3, Barbeau, M. 4, Frieder, D. 4
Affiliations: 1. IQVIA, London, UK, 2. IQVIA Gurugram, India, 3. IQVIA Mississauga, ON, Canada, 4. Valeant Canada LP, Laval QC, Canada
Publications: 
Document Types: , Poster
Countries: , Canada
Abstract: http://imsbrogancapabilities.com/pdf/rwe/valeantbrodalumab-nma-poster-ispor-final.pdf
Condition Year Language Analysis type
, Dermatology 2018 English , Meta analysis
 
 
pCPA CHANGES AND IMPACT TO MARKET ACCESS IN CANADA: RESULTS FROM AN OBSERVATIONAL CROSS-SECTIONAL STUDY
Authors: Minhas, Jagdeep, M.Biotech 1; Iqbal-Khan, Sarah, MBA 2; Laforty, Callahan, MSc 2; Millson, Brad, MBS 1
Affiliations: 1 1 Health Access and Outcomes, IQVIA, 535 Legget Drive, Kanata, ON, K2K 3B8 2 Health Access and Outcomes, IQVIA, 6755 Century Avenue, Mississauga, ON, L5N 6A4
Publications: 
2018 CADTH Symposium, April 15-17, 2018, Halifax, NS, Canada
Document Types: , Poster
Countries: , Canada
Abstract: http://imsbrogancapabilities.com/pdf/rwe/pcpa-changes-cadth-2018-poster-print.pdf
Condition Year Language Analysis type
, Miscellaneous 2018 English , Observational study
 
 
Potential Impact of Changes to Basket of Comparator Countries from PMPRB7 to PMPRB12 has on Canadian Product List Prices
Authors: van Doorn-Drennan, J. 1, Minhas, J. 1, Millson, B. 1, McCormick, J. 1
Affiliations: 1 IQVIA, Kanata, ON, Canada
Publications: 
ISPOR 23rd Annual International Meeting, May 19-23, 2018, Baltimore, MD, USA
Document Types: 
Countries: , Canada
Abstract: http://imsbrogancapabilities.com/pdf/rwe/pmprb-ispor-poster-print.pdf
Condition Year Language Analysis type
, Health economics 2018 English
 
 
Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada
Authors: 1. Sean Wharton Wharton Medical Clinic, Burlington, ON, Canada 2. Aiden R Liu Novo Nordisk Canada, Mississauga, ON, Canada 3. Arash Pakseresht Novo Nordisk Canada, Mississauga, ON, Canada 4. Emil Nørtoft Novo Nordisk A/S, Copenhagen, Denmark 5. Christiane L Haase Novo Nordisk A/S, Copenhagen, Denmark 6. Johanna Mancini IQVIA, Montreal, QC, Canada 7. G Sarah Power IQVIA, Mississauga, ON, Canada 8. Sarah VanderLelie Wharton Medical Clinic, Burlington, ON, Canada 9. Rebecca AG Christensen Wharton Medical Clinic, Burlington, ON, Canada
Affiliations: 1. Sean Wharton Wharton Medical Clinic, Burlington, ON, Canada 2. Aiden R Liu Novo Nordisk Canada, Mississauga, ON, Canada 3. Arash Pakseresht Novo Nordisk Canada, Mississauga, ON, Canada 4. Emil Nørtoft Novo Nordisk A/S, Copenhagen, Denmark 5. Christiane L Haase Novo Nordisk A/S, Copenhagen, Denmark 6. Johanna Mancini IQVIA, Montreal, QC, Canada 7. G Sarah Power IQVIA, Mississauga, ON, Canada 8. Sarah VanderLelie Wharton Medical Clinic, Burlington, ON, Canada 9. Rebecca AG Christensen Wharton Medical Clinic, Burlington, ON, Canada
Publications: 
ISPOR 23rd Annual International Meeting, May 19-23, 2018, Baltimore, MD, USA
Document Types: , Poster
Countries: , Canada
Abstract: http://imsbrogancapabilities.com/pdf/rwe/nn-ispor-poster-may-2018.pdf
Condition Year Language Analysis type
, Obesity 2018 English , Retrospective cohort analysis
 
 
Longitudinal Study of Patient Profile and Treatment Patterns of Omalizumab in Patients with Asthma Refractory to Inhaled Medications
Authors: Jason K. Lee 1, Suvina Amin 2, Michelle Erdmann 2, Atif Kukaswadia 3, Jelena Ivanovic 3, Aren Fischer 3, Alain Gendron 2,4
Affiliations: 1 Evidence Based Medical Educator Inc. Toronto, On, Canada and Section Head of Asthma at Canadian Society of Allergy and Clinical Immunology; 2 AstraZeneca, Mississauga, ON, Canada; 3 IQVIA, Toronto, ON, Canada; 4 Department of medicine, University of Montreal, Montreal, Canada
Publications: 
Document Types: , Poster
Countries: , Canada
Condition Year Language Analysis type
, Respiratory disease 2018 English , Longitudinal study, Retrospective cohort analysis
 
 
Persistence with Insulin Glargine 300 lU/mL compared to other Basal Insulins: A Canadian Retrospective Cohort Study
Authors: Kobina Quansah 1, Luc Sauriol 2, Atif Kukaswadia 1, Samantha Bremner 3, Bradley Millson 3
Affiliations: 1 IQVIA, Mississauga, ON, Canada, 2 Sanofi, Laval, QC, Canada, 3 IQVIA, Kanata, ON, Canada
Publications: 
ADA 2018, June 22-26, 2018, Orlando, FL
Document Types: , Poster
Countries: , Canada
Condition Year Language Analysis type
, Diabetes 2018 English , Retrospective cohort analysis
 
 
Identification of Incident Pancreatic Cancer in Administrative Health Data: A Validation Study by the Canadian Network for Observational Drug Effect Studies
Authors: Wu JW, Axzoulay L, Huang A, Paterson M, Wu F, Secrest MH, Filion K
Affiliations: Wu JW: Analysis Group; Secrest MH: IQVIA
Publications: 
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Document Types: , Abstract
Countries: , Canada
Condition Year Language Analysis type
, Database Validity and methodology, Diabetes, Oncology 2018 English , Database Study, Retrospective cohort analysis, Retrospective database analysis
 
 
TREATMENT AND DOSING PATTERNS AMONG PATIENTS WITH TYPE 2 DIABETES (T2D) INITIATING GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) IN SEVERAL COUNTRIES
Authors: Norrbacka K, Divino V, Boye K, Lebrec J, Dekoven M
Affiliations: Eli Lilly, IQVIA
Publications: 
ISPOR Europe 2018
Document Types: , Poster
Countries: , Belgium, Canada, France, Germany, Italy, Netherlands
Abstract: https://tools.ispor.org/ScientificPresentationsDatabase/Presentation/84796?pdfid=57383
Condition Year Language Analysis type
, Diabetes 2018 English , Retrospective database analysis
 
 
Canadian Study of Adherence Outcomes in HUMIRA® (Adalimumab) Patients – Three-Year Results from the COMPANION Study in Rheumatology Patients
Authors: Bessette L1, Millson B2, Sung M2, Gaetano T3, Latour M3, Laliberté MC3
Affiliations: 1 Department of Medicine, Laval University, Quebec City, Quebec, Canada 2 IMS Brogan, Kirkland, Quebec, Canada; 3AbbVie Corporation, St. Laurent, Quebec, Canada
Publications: 
Canadian Rheumatology Association 2017 Scientific Meeting, February 8-11, Ottawa, Canada
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/abbvie-cra-2017.pdf
Condition Year Language Analysis type
, Rheumatology 2017 English , Database Study
 
 
Impact of adalimumab’s patient support program on clinical outcomes in inflammatory bowel diseases: Results from the COMPANION study
Authors: Marshall JK1, Narula N1, Millson B2, Charland K2, Sung M2, Gaetano T3, McHugh K3, Latour M3, Laliberté MC3
Affiliations: 
Publications: 
European Crohn’s and Colitis Organization 2017 Conference, February 15-18, Barcelona, Spain
Document Types: , Poster
Countries: , Canada
Condition Year Language Analysis type
, Gastrointestinal disorders 2017 English , Retrospective database analysis
 
 
Prevalence of Primary Biliary Cholangitis in Canada: First National Study
Authors: Yoshida EM1, Thiele S2, Fischer A2, Mason A3, Shah H4, Peltekian K5, Hux M2, Borrelli R2
Affiliations: 1 Division of Gastroenterology, University of British Columbia 2 QuintilesIMS 3 University of Alberta 4 University of Toronto 5 Dalhousie University
Publications: 
CANADIAN DIGESTIVE DISEASES 2017 CONFERENCE, MARCH 3-6, BANFF, Canada
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/cddw-conference.pdf
Condition Year Language Analysis type
, Miscellaneous 2017 English , Retrospective cohort analysis
 
 
Canadian Study of Adherence Outcomes in HUMIRA® (Adalimumab) Patients: Three-Year Results from the COMPANION Study in Gastroenterology Patients
Authors: Marshall JK1, Millson B2, Sung M2, Gaetano T3, Latour M3, Laliberté MC3
Affiliations: 1 Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute; McMaster University, Hamilton, Ontario, Canada 2 IMS Brogan, Kirkland, Quebec, Canada 3 AbbVie Corporation, St. Laurent, Quebec, Canada
Publications: 
Canadian Digestive Diseases Week 2017 Annual Scientific Conference, March 3-6, Banff, Canada
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/cddw-abbvie.pdf
Condition Year Language Analysis type
, Gastrointestinal disorders 2017 English , Database Study
 
 
Privacy, Confidentiality, Security, and Ethics
Authors: L. Arbuckle, M. Chibba, K. El Emam, A. Cavoukian
Affiliations: Department of Pediatrics, Faculty of Medicine, University of Ottawa, 401 Smyth Road, Ottawa, Canada K1H 8L1 Electronic Health Information Laboratory, Children's Hospital of Eastern Ontario Research Institute, 401 Smyth Road, Ottawa, Ontario, Canada K1H 8L1
Publications: 
Population Health Informatics, Jones & Bartlett Learning
Document Types: , Book
Countries: , Canada
Condition Year Language Analysis type
, Methodology 2017 English , De-identification / anonymisation
 
 
HEALTH-ECONOMICS EVALUATIONS IN FRANCE, ENGLAND, CANADA AND AUTRALIA: COMPARISON OF METHODOLOGIES AND IMPACT ON DRUGS
Authors: Bucher D*, Abalan M-E*, Allou A*, Dumon L*, Vialard L *, Troubat A*, Maurel F*
Affiliations: IQVIA France - RWI
Publications: 
ISPOR 2017
Document Types: , Poster
Countries: , Australia, Canada, France, UK
Condition Year Language Analysis type
, Comparative Effectiveness & Health Technology Assessment 2017 English , Cost effectiveness, Literature Review, Pricing & Reimbursement, Review
 
 
SCHÉMAS THÉRAPEUTIQUES ET POSOLOGIQUES CHEZ DES PATIENTS AVEC UN DIABÈTE DE TYPE 2 (DT2) INITIANT UN TRAITEMENT PAR AGONISTE DU RÉCEPTEUR DU GLUCAGON-LIKE PEPTIDE 1 (AR GLP-1) EN EUROPE
Authors: Norrbacka K, Divino V, Dekoven M, Boye KS
Affiliations: Eli Lilly, IQVIA
Publications: 
Societé Francophone du Diabete 2017
Document Types: , Poster
Countries: , Belgium, Canada, France, Germany, Italy, Netherlands
Abstract: https://www.sfdiabete.org/sites/www.sfdiabete.org/files/files/evenements/17sfd_final_v12.pdf
Condition Year Language Analysis type
, Diabetes 2017 English , Retrospective database analysis
 
 
UTILIZATION OF RADIUM-223 DICHLORIDE (RA-223) IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN CANADA: A REAL-WORLD RETROSPECTIVE STUDY
Authors: Lapierre M, Fraelic A
Affiliations: IMS Health, Kirkland, QC, Canada, IMS Health, Canada, Kanata, QC, Canada
Publications: 
ISPOR 21st, May 21-25 - 2016 Washington DC USA
Value in Health, 2016, 19(3): A162
Document Types: , Poster
Countries: , Canada
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(16)01560-6/abstract
Condition Year Language Analysis type
, Oncology 2016 English , Retrospective database analysis
 
 
REAL-WORLD COMPARISON OF METASTATIC MELANOMA TREATMENTS BETWEEN ACADEMIC AND COMMUNITY HOSPITALS IN CANADA: A RETROSPECTIVE STUDY
Authors: Lapierre M
Affiliations: IMS Health, Kirkland, QC, Canada
Publications: 
ISPOR 21st, May 21-25 - 2016 Washingtown DC USA
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/metastatic-melanoma-ispor-poster-2016.pdf
Condition Year Language Analysis type
, Oncology 2016 English , Retrospective database analysis
 
 
CHARACTERIZATION OF STATIN EFFECTIVENESS USING REAL-WORLD DATA IN A CANADIAN POPULATION
Authors: Shojaie S, McCurdy S, Thiele S, Ching Chau L, Martin L, Charland K, Dobson-Belaire W, Duclos M, Borrelli R
Affiliations: IMS Health Brogan., Mississauga, ON, Canada, IMS health Brogan, Kirkland, QC, Canada, IMS Health Brogan, Mississauga, ON, Canada
Publications: 
ISPOR 21st, May 2016, Washington, DC USA
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/statin-ispor-poster-2016.pdf
Condition Year Language Analysis type
, Cardiovascular disease 2016 English , Retrospective database analysis
 
 
Second-line drug regimens in metastatic melanoma patients based on BRAF mutation status: A Canadian real-world retrospective study
Authors: Bremner S1, Lapierre M2, Fraelic A1, Stewart D1
Affiliations: 1 IMS Health, Kanata, ON, Canada 2 IMS Health, Kirkland, QC, Canada
Publications: 
2016 ASCO Annual Meeting
Document Types: , Abstract
Countries: , Canada
Abstract: http://meetinglibrary.asco.org/content/168312-176
Condition Year Language Analysis type
, Oncology 2016 English , Retrospective database analysis
 
 
No Substitution: Not just for Physicians Anymore
Authors: Gillman A, Fischer A
Affiliations: QuintilesIMS, Toronto, Canada
Publications: 
2016 Annual CAPT Conference
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/capt-poster-2016.pdf
Condition Year Language Analysis type
, Miscellaneous 2016 English , Review
 
 
pCPA/CDR/pCODR Changes and Impact to Market Access in Canada
Authors: Millson B, Zhang Y
Affiliations: IMS Brogan, A unit of IMS Health, Kirkland, QC, Canada
Publications: 
2016 ISPOR Conference
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/hta-ispor-poster-2016.pdf
Condition Year Language Analysis type
, Pricing and reimbursement 2016 English , Database Study
 
 
Excess Healthcare Resource Utilization in Obesity Pharmacotherapy Candidates in Canada
Authors: Feroz T1, Charland K2, Heembrock S2, Borrelli R2, Skovgaard R1
Affiliations: 1 NovoNordisk Canada Inc. Canada 2 IMS Brogan Canada
Publications: 
13th International Conference on Obesity, 2016, May 1-4, Vancouver, Canada
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/obesity-conference-poster-2016.pdf
Condition Year Language Analysis type
, Drug Utlization Study, Obesity 2016 English , Retrospective cohort analysis
 
 
Estimating Canadian Heart Failure Prevalence Using Prescription Treatment Patterns
Authors: Jobin Gervais K1, Zaour N1, Caron J2, Borrelli R2, Fischer A2
Affiliations: 1 Novartis Pharmaceuticals Canada Inc., Dorval, QC, Canada 2 IMS Brogan, Mississauga, ON, Canada
Publications: 
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/novartis-heart-failure-poster-2016.pdf
Condition Year Language Analysis type
, Cardiovascular disease 2016 English , Retrospective cohort analysis
 
 
Characteristics of Patients with Mild to Severe Asthma in Canada
Authors: Gerega S1, Millson B1, Charland K1, Barakat S2, Sun X3, Jimenez R2, Waserman S4, FitzGerald JM5
Affiliations: 1 IMS Brogan, Kirkland, Québec, Canada 2 Teva Pharmaceutical Industries, Montréal, Québec, Canada 3 Teva Pharmaceutical Industries, Frazer, Pennsylvania, United States 4 McMaster University, Hamilton, Ontario, Canada 5 The Lung Centre, Vancouver, British Columbia, Canada
Publications: 
Canadian Society of Allergy and Clinical Immunology (CSACI), 2016, Sept. 29 - Oct. 2, Montréal, Canada
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/teva-poster.pdf
Condition Year Language Analysis type
, Respiratory disease 2016 English , Database Study, Retrospective database analysis
 
 
Canadian Study of Outcomes in HUMIRA® (Adalimumab) Patients with Support for Adherence - Dermatology Results from the COMPANION Study
Authors: Shear N1,2, Bessette L3, Marshall JK4, Lebovic G5,6, Gerega S7, Millson B7, Gaetano T8, Gazel S8, Latour M8, Laliberté MC8
Affiliations: 1 Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada 2 Department of Medicine, Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada 3 Department of Medicine, Laval University, Quebec City, Quebec, Canada; 4Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute; McMaster University, Hamilton, Ontario, Canada 5 Applied Health Research Centre, St. Michael’s Hospital, Toronto, Ontario, Canada 6 Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada 7 IMS Brogan, Kirkland, Quebec, Canada 8 AbbVie Corporation, St. Laurent, Quebec, Canada
Publications: 
Dermatology Update 2016 Annual Meeting, November 3-6, Montreal, Canada
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/abbvie-dermatology-poster-2016.pdf
Condition Year Language Analysis type
, Dermatology, Medication compliance 2016 English , Database Study
 
 
Canadian Study of Outcomes in HUMIRA® (Adalimumab) Patients with Support for Adherence - Results from the COMPANION Study
Authors: Latour M1, Gerega S2, Millson B2, Bessette L3, Marshall JK4, Lebovic G5,6, Sung M2, Oraichi D2, Gaetano T1, Gazel S1, Laliberté MC1
Affiliations: 1 AbbVie Corporation, St. Laurent, Quebec, Canada 2 IMS Brogan, Kirkland, Quebec, Canada 3 Department of Medicine, Laval University, Quebec City, Quebec, Canada 4 Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada 5 Applied Health Research Centre, St. Michael’s Hospital, Toronto, Ontario, Canada 6 Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
Publications: 
American College of Gastroenterology 2016 Conference, October 14-19, Las Vegas, USA
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/abbvie-humira-poster-2016.pdf
Condition Year Language Analysis type
, Gastrointestinal disorders, Medication compliance 2016 English , Database Study
 
 
Canadian Study of Outcomes in HUMIRA® (Adalimumab) Patients with Support for Adherence - Results from the COMPANION Study
Authors: Gerega S1, Millson B1, Bessette L2, Marshall JK3, Lebovic G4,5, Sung M1, Oraichi D1, Gaetano T6, Gazel S6, Latour M6, Laliberté MC6
Affiliations: 1 IMS Brogan, Kirkland, Quebec, Canada 2 Department of Medicine, Laval University, Quebec City, Quebec, Canada 3 Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute; McMaster University, Hamilton, Ontario, Canada 4 Applied Health Research Centre, St. Michael’s Hospital, Toronto, Ontario, Canada 5 Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada 6 AbbVie Corporation, St. Laurent, Quebec, Canada
Publications: 
American College of Rheumatology 2016 Annual Meeting, November 11-16, Washington DC, USA
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/abbvie-acr-poster-2016.pdf
Condition Year Language Analysis type
, Medication compliance, Rheumatology 2016 English , Database Study
 
 
A quantitative evaluation of the growth in non-physician prescribing in Canada and the resultant impact to key provinces and therapeutic areas
Authors: Shojaie S, Trickett R, Dobson-Belaire WN
Affiliations: QuintilesIMS, Montreal, Canada
Publications: 
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/a-quantitative-evaluation-of-the-growth-in-non-physician.pdf
Condition Year Language Analysis type
, Miscellaneous 2016 English , Retrospective database analysis
 
 
A Novel Method Using Prescription Treatment Patterns to Estimate Heart Failure Prevalence in Canada
Authors: Jobin Gervais K1, Zaour N1, Caron J2, Borrelli R2, Fischer A2
Affiliations: 1 Novartis Pharmaceuticals Canada Inc., Dorval, QC, Canada 2 IMS Brogan, Mississauga, ON, Canada
Publications: 
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/novartis-ispor-poster-2016.pdf
Condition Year Language Analysis type
, Cardiovascular disease 2016 English , Retrospective cohort analysis
 
 
The Clinical and Economic Impact of Probiotics Consumption on Respiratory Tract Infections: Projections for Canada.
Authors: Lenoir-Wijnkoop I1,2, Gerlier L3, Roy D4, Reid G5
Affiliations: 1 Utrecht University, Utrecht, The Netherlands 2 Danone Company, Paris, France 3 QuintilesIMS, Zaventem, Belgium 4 Laval University, Quebec, Canada 5 University of Western Ontario, London, Ontario, Canada
Publications: 
PLoS One., 2016, Nov, 10, 11(11)
Document Types: , Abstract
Countries: , Canada
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/27832195
Condition Year Language Analysis type
, Respiratory disease 2016 English
 
 
Pharmaceutical expenditure on drugs for rare diseases in Canada: a historical (2007-13) and prospective (2014-18) MIDAS sales data analysis.
Authors: Divino V1, DeKoven M2, Kleinrock M3, Wade RL2, Kim T4, Kaura S5.
Affiliations: 1 IMS Health, 8280 Willow Oaks Corporate Drive, Suite 775, Fairfax, VA, 22031, USA. vdivino@us.imshealth.com. 2 IMS Health, 8280 Willow Oaks Corporate Drive, Suite 775, Fairfax, VA, 22031, USA. 3 IMS Institute for Healthcare Informatics, One IMS Drive, Plymouth Meeting, PA, 19462, USA. 4 Celgene, 6755 Mississauga Rd, Suite 600, Mississauga, ON, L5N 7Y2, Canada. 5 Celgene, 86 Morris Avenue, H-222H, Summit, NJ, 07901, USA.
Publications: 
Orphanet J Rare Dis. 2016 May 21;11(1):68
Document Types: , Article
Countries: , Canada
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875716/
Condition Year Language Analysis type
, Rare Diseases 2016 English , Budget impact
 
 
Cost-effectiveness of Radium-223 Dichloride (Radium-223) in Alsympca: A Cost-effectiveness analysis of Radium-223+Best standard of care (BSOC) compared with placebo+BSOC in treatment of Castration-Resistant Prostate Cancer (CRPC) and symptomatic bone metastases in Canada
Authors: Henricks P1, Cislo P2, Zhan L2, Beaudet A3, Grabbi E4, Lloyd A4, Fleshner N5, Chin W6
Affiliations: 1Bayer Inc, Toronto, ON, Canada, 2Bayer HealthCare, Whippany, NJ, USA, 3IMS Health, Basel, Switzerland, 4IMS Health, London, UK, 5Princess Margaret Hospital, University Health Network, Toronto, ON, Canada, 6ILEX Consulting, Toronto, ON, Canada
Publications: 
ISPOR 20th Annual International Meeting, Philadelphia, PA, USA, May 16-20 2015
Document Types: , Poster
Countries: , Canada
Abstract: https://www.ispor.org/research_pdfs/49/pdffiles/PCN74.pdf
Condition Year Language Analysis type
, Oncology 2015 English , Cost effectiveness
 
 
DISCOVERing treatment of type 2 diabetes in real world settings using electronic medical record databases
Authors: Charbonnel B1, Gomes MB2, Khunti K3, Nicolucci A4, Pocock S5, Shestakova MV6, Shimomura I6, Fenici P7, García-Álvarez L8, Hammar N9, Hashigami K10, Hiller J8, Medina J11, Surmont FA12, Ji L13
Affiliations: 1University of Nantes, Nantes, France; 2Rio de Janeiro State University, Rio de Janeiro, Brazil; 3University of Leicester, Leicester, UK; 4Center for Outcomes Research and Clinical Epidemiology, Pescara, Italy; 5London School of Hygiene and Tropical Medicine, London, UK; 6Endocrinology Research Center, Moscow, Russian Federation; 7Osaka University, Osaka, Japan; 8AstraZeneca, Cambridge, UK; 9IMS Health, London, UK; 10AstraZeneca, Mölndal, Sweden; 11AstraZeneca, Tokyo, Japan; 12AstraZeneca, Madrid, Spain; 13AstraZeneca, Shanghai, China; 14Diabetes Center, Peking University People’s Hospital, Beijing, China
Publications: 
EASD - 51st Annual Meeting of the European Association for the Study of Diabetes, 14–18 September 2015, Stockholm, Sweden
Document Types: , Poster
Countries: , Canada, France, Germany, UK
Abstract: http://www.easdvirtualmeeting.org/resources/discovering-treatment-of-type-2-diabetes-in-real-world-settings-using-electronic-medical-record-databases--3
Condition Year Language Analysis type
, Diabetes 2015 English , Real World Data, Retrospective database analysis
 
 
THE COST OF ACUTE CARE HOSPITALIZATIONS ASSOCIATED WITH CHRONIC HEART FAILURE IN CANADA
Authors: Fischer AA1, Liu N1, Borelli R1, Barbeau M2, Zaour N2
Affiliations: 1IMS Brogan, Mississauga, ON, Canada, 2Novartis Pharmaceuticals Canada Inc., Dorval, QC, Canada
Publications: 
ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/ispor-milan-poster.pdf
Condition Year Language Analysis type
, Cardiovascular disease 2015 English , Cost analysis
 
 
THE BUDGET IMPACT OF ORPHAN DRUGS IN THE US AND CANADA: A 2007-2013 MIDAS SALES DATA ANALYSIS
Authors: Divino V1, DeKoven M1, Kim T2, Kleinrock M1, Wade RL1, Kaura S3
Affiliations: 1IMS Health, Fairfax, VA, USA, 2Celgene Corporation, Mississauga, ON, Canada, 3Celgene Corporation, Summit, NJ, USA
Publications: 
ISPOR 18th Annual European Congress Milan, Italy November, 2015
Value in Health, 2015, 18(7): A666
Document Types: , Poster
Countries: , Canada, USA
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/26533734
Condition Year Language Analysis type
2015 English , Budget impact
 
 
Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study.
Authors: Emery P1, Gottenberg JE2, Rubbert-Roth A3, Sarzi-Puttini P4, Choquette D5, Taboada VM6, Barile-Fabris L7, Moots RJ8, Ostor A9, Andrianakos A10, Gemmen E11, Mpofu C12, Chung C13, Gylvin LH12, Finckh A14.
Affiliations: 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK. 2Department of Rheumatology, CHU Strasbourg, Strasbourg, France. 3University of Cologne, Cologne, Germany. 4L Sacco University Hospital, Milan, Italy. 5University of Montreal, Montreal, Canada. 6Facultad de Medicina, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain. 7Hospital de Especialidades Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, México City, Mexico. 8Department of Rheumatology, University of Liverpool, Liverpool, UK. 9Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. 10Hellenic Foundation for Rheumatological Research, Athens, Greece. 11Quintiles, Rockville, Maryland, USA. 12F Hoffmann-La Roche Ltd, Basel, Switzerland. 13Genentech Inc, San Francisco, California, USA. 14University Hospital of Geneva, Geneva, Switzerland.
Publications: 
Ann Rheum Dis. 2015 Jun;74(6):979-84
Document Types: , Article
Countries: , Canada, Colombia, France, Germany, Greece, Italy, Mexico, Norway, Portugal, Spain, UK
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431330/
Condition Year Language Analysis type
, Comparative Effectiveness & Health Technology Assessment, Rheumatology 2015 English , Clinical setting: hospital, clinical setting: Secondary care, Prospective study, RWLPR (Real-World Late Phase Research-quintiles
 
 
Using Electronic Medical Records to Better Understand the Relationship Between Testing, Diagnosis and Treatment of Gonorrhea in Ontario
Authors: Gillman, A
Affiliations: IMS Brogan, Toronto, Canada
Publications: 
CAPT Conference 2015
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/capt-2015-conference.pdf
Condition Year Language Analysis type
, Infectious disease 2015 English , Longitudinal study
 
 
Use of Attention-Deficit/Hyperactivity Disorder Drugs in Canada, 2010-2014
Authors: Aziz S1, Gillman A2, Griffiths J1
Affiliations: 1 Marketed Health Products Directorate, Health Canada, Ottawa, ON, Canada 2 IMS Brogan, Toronto, ON, Canada
Publications: 
ISPOR 2015
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/ispor-2015-use-of-adhd-drugs-in-canada.pdf
Condition Year Language Analysis type
, Mental health 2015 English , Retrospective database analysis
 
 
The evolving role of real-world evidence to support policy and practice
Authors: Corner N1, Fenwick P2, Brown J3, Husereau D4
Affiliations: IMS Health Brogan, Montreal, Canada 2 Alberta Health Services, Alberta, Canada 3 Government Affairs and Market Access, Janssen Inc. 4 Institute of Health Economics
Publications: 
2015 CADTH Symposium
Document Types: , Presentation
Countries: , Canada
Abstract: http://arc.imshealth.com/gm/document-1.9.7094451/Concurrent%20Session%20E6_Real-World%20Evidence%20to%20Support%20Policy%20and%20Practice_Neil%20Corner.pptx
Condition Year Language Analysis type
2015 English
 
 
The Burden of Gout in the Canadian Primary Care Population
Authors: Williams DM1, Cowan C1, Gendron A1, Goodfield J2, Oraichi D2, Fischer A2, Borrelli R2, Liu N2, Dziarmaga A1
Affiliations: 1 AstraZeneca Canada Inc., Mississauga, ON, Canada, L4Y 1M4 2 IMS Brogan, A unit of IMS, Mississauga, ON, Canada L5N 6A4
Publications: 
ISPOR 2015
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/canadian-burden-of-gout-poster-ispor-may-2015.pdf
Condition Year Language Analysis type
, Miscellaneous 2015 English , Retrospective database analysis
 
 
Real-World Assessment of Psoriasis Medication Costs Associated With Biologics Treatment in a Canadian Psoriasis Population
Authors: Shear N1, Dobson-Belaire W, Tey G, Goodfield J, Liu FF, Khan Z
Affiliations: 1 University of Toronto, Toronto, ON, Canada 2 IMS Brogan, Mississauga, ON, Canada 3 Celgene Inc., Mississauga, ON, Canada 4 Celgene Corporation, Summit, NJ, USA
Publications: 
23rd World Congress of Dermatology
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/biologic-cost-poster-2015.pdf
Condition Year Language Analysis type
, Dermatology 2015 English , Retrospective database analysis
 
 
Psoriasis Treatment Progression and Biologic Utilization: A Canadian Retrospective Study
Authors: Shear N1, Dobson-Belaire W2, Tey G2, Reidel K3, Liu FF4, Khan Z5
Affiliations: 1 Department of Medicine (Dermatology, Clinical Pharmacology), University of Toronto, Toronto, Ontario, Canada and Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada 2 IMS Brogan, a unit of IMS Health, Mississauga, Ontario, Canada 3 IMS Brogan, a unit of IMS Health, Kirkland, Québec, Canada 4 Celgene Inc., Mississauga, Ontario, Canada 5 Celgene Corporation, Summit, NJ, USA
Publications: 
73rd Annual Meeting of the American Academy of Dermatology
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/canadian-drug-claim-database-poster-2015.pdf
Condition Year Language Analysis type
, Dermatology 2015 English , Retrospective database analysis
 
 
Metastatic Melanoma Patient Characteristics as a Determining Factor for Braf Gene Mutation Testing and Treatment in Canada – a retrospective cohort study
Authors: Djokic S1, Lapierre M2
Affiliations: 1 IMS Health, Ottawa, ON, Canada 2 IMS Health, Kirkland, QC, Canada
Publications: 
ISPOR 20th Annual International Meeting
Document Types: , Poster
Countries: , Canada
Abstract: https://www.ispor.org/ScientificPresentationsDatabase/Presentation/55700
Condition Year Language Analysis type
, Oncology 2015 English , Retrospective cohort analysis
 
 
Access to New Medicines in Public Drug Plans: Canada and Comparable Countries 2015 Annual Report
Authors: Millson B1, Thiele S1, Zhang Y1, Dobson-Belaire W1, Skinner B2
Affiliations: 1 IMS Health Canada Inc., 16720 Trans-Canada Highway, Kirkland, Quebec H9H 5M3 2 Innovative Medicines Canada, 55 Metcalfe Street, Suite 1220, Ottawa, Ontario K1P 6L5
Publications: 
Innovative Medicines Canada Annual Report 2016
Document Types: , Report
Countries: , Canada
Abstract: http://innovativemedicines.ca/wp-content/uploads/2016/05/20160524_Access_to_Medicines_Report_EN_Web.pdf
Condition Year Language Analysis type
, Health economics, Health policy 2015 English , Review
 
 
Evolution of BRAF gene mutation testing and treatment options in BRAF mutation carriers in Canada
Authors: Djokic S
Affiliations: IMS Brogan, Kanata, ON, Canada
Publications: 
2015 ASCO Annual Meeting
Document Types: , Abstract
Countries: , Canada
Abstract: http://meetinglibrary.asco.org/content/152450-156
Condition Year Language Analysis type
, Oncology 2015 English , Retrospective database analysis
 
 
Dose Pattern Analysis for Biologics in the Treatment of Psoriasis in Canada: Information Retrieved from Administrative Claims Databases
Authors: Gregory V1, Liu N2, Gerega S3, Robertson C2, Barbeau M1
Affiliations: 1 Novartis Pharmaceuticals Canada Inc., Dorval, QC, Canada 2 IMS Health, Mississauga, ON, Canada 3 IMS Health Brogan, Kirkland, QC, Canada
Publications: 
ISPOR 20th Annual International Meeting
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/novartis-IMS-biologics-dose-escalation.pdf
Condition Year Language Analysis type
, Dermatology 2015 English , Longitudinal study, Retrospective cohort analysis
 
 
Coverage Limits on Blood Glucose Test Strip Reimbursement for Diabetics in Canada: Utilization Impact for Diabetic Patients in the Ontario Public Drug Program (OPDP)
Authors: Bosnic N1, Goodfield J1, Robertson C1, Zhang Y1
Affiliations: 1 Health Economics and Outcomes Research, IMS Brogan Health, Ontario, Canada
Publications: 
ISPOR 20th Annual International Meeting,
Document Types: , Presentation
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/ispor-bosnic-deck-impact-of-diabetes-test-strip-coverage-limits-in-canada.pdf
Condition Year Language Analysis type
, Diabetes 2015 English , Retrospective database analysis
 
 
Comparison of Public Reimbursement for Oncology versus Non-oncology Drugs in Canada
Authors: Bosnic N, Donepudi K, Goodfield J, Zhang Y
Affiliations: 1 IMS Brogan, Kanata, ON, Canada 2 IMS Brogan, Mississauga, ON, Canada
Publications: 
2015 ASCO Annual Meeting
Document Types: , Abstract
Countries: , Canada
Abstract: http://meetinglibrary.asco.org/content/153179-156
Condition Year Language Analysis type
, Oncology 2015 English , Retrospective database analysis
 
 
Comparison of patient characteristics and chromosomal abnormalities by first-line treatment in chronic lymphoid leukemia (CLL) patients in Canada
Authors: Marc Lapierre
Affiliations: IMS Brogan, Kirkland, QC, Canada
Publications: 
2015 ASCO Annual Meeting
Document Types: , Abstract
Countries: , Canada
Abstract: http://meetinglibrary.asco.org/content/152361-156
Condition Year Language Analysis type
, Oncology 2015 English , Retrospective cohort analysis
 
 
Analysis of Etanercept Treatment Patterns and Reimbursement Gaps in Patients Transitioning From Private to Public Drug Plans (poster)
Authors: Millson B1, Poulin-Costello M2, Garces K2
Affiliations: 1 IMS Health Canada Inc, Kirkland, QC, Canada 2 Amgen Canada, Mississauga, ON, Canada
Publications: 
ISPOR Annual International Meeting 2015
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/amgen-ppswitch-poster.pdf
Condition Year Language Analysis type
, Medication compliance 2015 English , Retrospective cohort analysis
 
 
Canadian Retrospective Claim Data Analysis of Biologics Switching and Retention Patterns in Psoriasis Patients (poster)
Authors: Millson B1, Poulin-Costello M2, Garces K2
Affiliations: 1 IMS Brogan, Kirkland, QC, Canada 2 Amgen Canada Inc., Mississauga, ON, Canada
Publications: 
ISPOR 20th Annual International Meeting
Document Types: , Poster
Countries: , Canada
Abstract: https://www.ispor.org/ScientificPresentationsDatabase/Presentation/54789
Condition Year Language Analysis type
, Dermatology, Drug Utlization Study 2015 English , Retrospective database analysis
 
 
Comparison of Compliance and Discontinuation Rates Among MS Patients Treated with Fingolimod and Other Disease-Modifying Therapies: A Canadian Retrospective Claims Analysis
Authors: Haddad P1, Duquette P2, Yeung M3, Lamarche AM1, Fraelic A4, Chan S4
Affiliations:  1Novartis Pharmaceuticals Canada Inc., Dorval, Quebec, CANADA 2 Notre Dame Hospital, Université de Montréal, Montreal, Quebec, CANADA 3 University of Calgary, Multiple Sclerosis Clinic, Calgary, Alberta, CANADA 4 IMS Brogan, a unit of IMS Health Canada Inc., Montreal, Quebec, CANADA
Publications: 
ISPOR Annual European Congress 2015
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/ispor-2015-novartis-patients-poster.pdf
Condition Year Language Analysis type
, Medication compliance 2015 English , Retrospective database analysis
 
 
Metastatic Melanoma Patient Characteristics as a determining Factor for BRAF Gene Mutation Testing and treatment in Canada.
Authors: Djokic S, Lapierre M
Affiliations: IMS Health Canada
Publications: 
IPSOR 2015 Annual Meeting
Document Types: , Poster
Countries: , Canada
Abstract: https://www.ispor.org/research_pdfs/49/pdffiles/PCN137.pdf
Condition Year Language Analysis type
, Oncology 2015 English , Retrospective database analysis
 
 
Comparison of patient characteristics and chromosomal abnormalities by first-line treatment in chronic lymphoid leukemia (CLL) patients in Canada.
Authors: Lapierre M
Affiliations: IMS Health Canada
Publications: 
ASCO 2015 Annual Meeting, 2015, May 29-June 2, Chicago, Illinois, USA
Document Types: , Abstract
Countries: , Canada
Abstract: http://meetinglibrary.asco.org/record/112933/abstract
Condition Year Language Analysis type
, Oncology 2015 English , Retrospective database analysis
 
 
Evolution of BRAF gene mutation testing and treatment options in BRAF Mutation carriers in Canada.
Authors: Djokic S
Affiliations: IMS Health Canada
Publications: 
ASCO 2015 Annual Meeting, 2015, May 29-June 2, Chicago, Illinois, USA
Document Types: , Abstract
Countries: , Canada
Abstract: http://meetinglibrary.asco.org/record/114023/abstract
Condition Year Language Analysis type
, Oncology 2015 English , Observational study, Retrospective cohort analysis
 
 
Cost-Effectiveness of Rivaroxaban for the Treatment of Pulmonary Embolism in Canada
Authors: Levac B1, Marrie J1, Chin W2, Hassan F3, Bamber L4, McLeod EJ3
Affiliations: 1Bayer Inc., ON, Canada, 2ILEX Consulting Inc., ON, Canada, 3IMS Health, United Kingdom, 4Bayer Healthcare, Germany
Publications: 
ISPOR, 19th Annual International Meeting, Montreal, Canada, May 31 - June 4th 2014 - PCV90
Value in Health, 2014, 17(3): A117-A118
Document Types: , Poster
Countries: , Canada
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(14)00735-9/abstract
Condition Year Language Analysis type
, Cardiovascular disease 2014 English , Cost effectiveness
 
 
Validation of a Canadian Primary Care Electronic Medical Record Database
Authors: Dziarmaga A1, Frise S1,3, Tarride JE1,4, Corner N2
Affiliations: 1 AstraZeneca Canada Inc., Mississauga, ON, Canada 2 IMS Brogan Canada, Kirkland, QC 3 Dalla Lana School of Public Health, University of Toronto 4 Department of Clinical Epidemiology & Biostatistics, McMaster University
Publications: 
CAPT 2014 Conference
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/healthcare-capt.pdf
Condition Year Language Analysis type
, Miscellaneous 2014 English , Longitudinal study
 
 
Using Electronic Medical Records as Real World Evidence to Understand the Impact of Flu Vaccinations on Patient Health
Authors: Gillman A1
Affiliations: 1 IMS Brogan, Toronto, Canada
Publications: 
CAPT 2014
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/capt2014-conference-poster-final-corrected.pdf
Condition Year Language Analysis type
, Diabetes, Infectious disease 2014 English , Longitudinal study
 
 
Understanding Treatment Patterns of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Proton Pump Inhibitors (PPIs) in Patients with the Signs and Symptoms of Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS)
Authors: Dziarmaga A1, Reide Kl2, White R1, Tarride J1, Corner N2
Affiliations: 1 A straZeneca 2 IMS Brogan Canada (A Unit of IMS Health)
Publications: 
ISPOR 2014
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/nsaids-ispor-banner-2014-print.pdf
Condition Year Language Analysis type
, Rheumatology 2014 English , Longitudinal study
 
 
Reimbursement Patterns for Enbrel® (etanercept) As Senior Patients Transition From Private to Public Drug Plan Insurance
Authors: Garces K1 , Poulin-Costello M1, Millson B2
Affiliations: 1 Amgen Canada, Mississauga, ON, Canada 2 IMS Health Canada Inc, Kirkland, QC, Canada
Publications: 
CAPT 2014
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/amgencapt-poster-print.pdf
Condition Year Language Analysis type
, Pricing and reimbursement 2014 English , Retrospective cohort analysis
 
 
Impact of the Pan-Canadian Pricing Alliance Initiative on Time to Listing in Canada: An Analysis of Pharmaceutical Coverage
Authors: Robertson C, Zhang Y, Bosnic N
Affiliations: IMS Brogan, Canada
Publications: 
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/impact-of-the-pan-canadian-pricing-alliance.pdf
Condition Year Language Analysis type
, Miscellaneous 2014 English , Retrospective database analysis
 
 
Identifying Psoriasis and Psoriatic Arthritis Patients in Retrospective Databases When a Diagnosis Code Is Not Available: A Validation Study Comparing Medication/Prescriber Visit Based Algorithms to Diagnosis Codes
Authors: Dobson-Belaire W1, Goodfield J1, Borrelli R1, Liu F2, Khan Z3
Affiliations: 1 IMS Brogan, a unit of IMS Health, Mississauga, ON, Canada 2 Celgene Inc., Mississauga, ON, Canada 3 Celgene Corporation, Summit, NJ, USA
Publications: 
ISPOR 2014
Document Types: , Poster
Countries: , Canada
Abstract: https://www.ispor.org/research_pdfs/48/pdffiles/PRM214.pdf
Condition Year Language Analysis type
, Dermatology 2014 English , Retrospective database analysis
 
 
Diabetes complexities drive resource consumption in Canada
Authors: Borrelli R, Mokin S, Sung M
Affiliations: IMS Brogan
Publications: 
Accesspoint, 2014, 5(9): 15-19
Document Types: , Article
Countries: , Canada
Condition Year Language Analysis type
, Diabetes 2014 English , Retrospective database analysis
 
 
Assessment of a Canadian Primary Care Electronic Medical Record Database for Use in Observational Studies
Authors: Frise S1,3, Reidel K2, Tarride JE1,4, Corner N2, Dziarmaga A1
Affiliations: 1 AstraZeneca Canada Inc., Mississauga, ON, Canada 2 IMS Brogan Canada, Kirkland, QC 3 Dalla Lana School of Public Health, University of Toronto 4 Department of Clinical Epidemiology & Biostatistics, McMaster University
Publications: 
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/assessment-of-a-primary-care-database.pdf
Condition Year Language Analysis type
, Miscellaneous 2014 English , Observational study
 
 
Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study
Authors: Lind M1, Garcia-Rodriguez LA, Booth GL, Cea-Soriano L, Shah BR, Ekeroth G & Lipscombe LL
Affiliations: 1 Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg Institute of Medicine Department of Molecular and Clinical Medicine
Publications: 
Diabetologia. 2013 Dec;56(12):2765. doi: 10.1007/s00125-013-2949-2. Epub 2013 Jun 22
Document Types: , Article
Countries: , Canada, UK
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/24114114
Condition Year Language Analysis type
, Diabetes 2013 English , Retrospective database analysis
 
 
ASSESSMENT OF A CANADIAN PRIMARY CARE ELECTRONIC MEDICAL RECORD DATABASE FOR USE IN OBSERVATIONAL STUDIES
Authors: Frise S1, Reidel K2, Tarride JE1, Corner N2, Dziarmaga A1
Affiliations: 1 AstraZeneca Canada Inc., Mississauga, ON, Canada, 2 IMS Brogan Canada, Kirkland, QC, Canada
Publications: 
ISPOR 16th Annual European Congress, Dublin,November, 2013
Value in Health, 2013, 16(7): A582
Document Types: , Poster
Countries: , Canada
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)03503-1/abstract
Condition Year Language Analysis type
, Database Validity and methodology 2013 English , Retrospective database analysis
 
 
Using Anonymized Longitudinal Patient Data to Monitor the Impact of Reimbursement Policies on Patient Compliance
Authors: Gillman, A
Affiliations: IMS Brogan, Toronto, Canada
Publications: 
CAPT 2013
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/capt-agillman-final.pdf
Condition Year Language Analysis type
, Diabetes 2013 English , Longitudinal study
 
 
Cost-effectiveness of rivaroxaban in the prevention of venous thromboembolism: A Canadian analysis using the Ontario Ministry of Health Perspective
Authors: McDonald H1, Diamantopoulos A2, Wells P3, Lees M4, Folkerts K5, Forster F6, Ananthapavan J6
Affiliations: 1 Bayer Inc., Toronto, Canada 2 Symmetron Limited, London, UK 3 Department of Medicine, Ottawa Hospital and University of Ottawa, Canada 4 Bayer plc, Uxbridge, UK 5 Bayer Pharma AG, Wuppertal, Germany 6 IMS Health, London, UK
Publications: 
Journal of Medical Economics Vol. 15, No. 5, 2012, 1–12
Document Types: , Article
Countries: , Canada
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/22494267
Condition Year Language Analysis type
, Cardiovascular disease 2012 English , Cost effectiveness
 
 
Cost of self-monitoring of blood glucose in Canada among patients on an insulin regimen for diabetes
Authors: Yeaw J1, Lee WC1, Wolden ML2, Christensen T2, Groleau D2
Affiliations: 1 IMS Health, Redwood City, CA, US 2 Novo Nordisk, Copenhagen, Denmark
Publications: 
Diabetes Ther. 2012 Nov;3(1):7. Epub 2012 Jun 27.
Document Types: , Article
Countries: , Canada
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/22736405
Condition Year Language Analysis type
, Diabetes 2012 English , Retrospective cohort analysis
 
 
Development and validation of the self-completed ascites impact measure to understand patient motivation for requesting a paracentesis.
Authors: Crawford B1, Piaut E2, Gotlieb W3, Joulain F4
Affiliations: 1 Mapi Values, Tokyo, Japan 2 2Mapi Values, Boston, MA, USA 3 McGill University, Montreal, Quebec, Canada 4Sanofi, Paris, France
Publications: 
Patient Relat Outcome Meas. 2012 Jul; 3: 21–30. Published online 2012 Jun 21. doi: 10.2147/PROM.S28179
Document Types: , Article
Countries: , Canada, USA
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417936/
Condition Year Language Analysis type
, Gastrointestinal disorders 2012 English , Patient questionnaire
 
 
Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence.
Authors: Johnson JA1, Carstensen B2 3, Witte D2, Bowker SL1, Lipscombe L4 & Renehan AG5
Affiliations: 1 School of Public Health, University of Alberta, 2 Steno Diabetes Center, 3 2 Department of Biostatistics, University of Copenhagen 4 Women’s College Hospital, University of Toronto, 5 School of Cancer and Enabling Sciences, University of Manchester
Publications: 
Diabetologia. 2012 Jun;55(6):1607-18. doi: 10.1007/s00125-012-2525-1. Epub 2012 Apr 4.
Document Types: , Article
Countries: , Canada, UK
Abstract: http://link.springer.com/article/10.1007/s00125-012-2525-1/fulltext.html
Condition Year Language Analysis type
, Diabetes, Oncology 2012 English , Retrospective cohort analysis, Retrospective database analysis
 
 
Canada’s pharmaceutical industry and prospects
Authors: IMS Brogan
Affiliations: IMS Brogan, Industry Canada
Publications: 
Industry Canada, Government of Canada
Document Types: , Report
Countries: , Canada
Abstract: https://www.ic.gc.ca/eic/site/lsg-pdsv.nsf/eng/hn01768.html
Condition Year Language Analysis type
2012 English , Review
 
 
Modeling the lifetime costs of insulin glargine and insulin detemir in type 1 and type 2 diabetes patients in Canada: a meta-analysis and a cost-minimization analysis
Authors: Guillermin A1, Samyshkin Y1, Wright D1, Nguyen T1, Villeneuve J2
Affiliations: 1 IMS Health, London, UK 2 Sanofi-Aventis, Laval, Canada
Publications: 
Journal of Medical Economics 2011; 14(2):207-216
Document Types: , Article
Countries: , Canada
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/21361858
Condition Year Language Analysis type
, Diabetes 2011 English , Cost minimization, Meta analysis
 
 
PDB78 Randomized clinical trial (RCT) design and analytic issues impacting assumed clinical effects and results of cost-effectiveness analyses: Illustration from a recent Canadian report on the cost-effectiveness of blood glucose test strips for type 2 diabetes.
Authors: Tunis S
Affiliations: IMS Health Inc., Falls Church, VA, USA
Publications: 
ISPOR 15th Annual International Meeting, May 15-19, 2010, Atlanta, GA, USA
Value in Health, 2010, 13(3): A68
Document Types: , Poster
Countries: , Canada
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(10)72320-2/abstract
Condition Year Language Analysis type
, Diabetes 2010 English , Cost effectiveness
 
 
Systemic lupus erythematosus (SLE) is costly for the Health care system and workplace: a systematic literature review
Authors: Doria A1, Grandfils N2, Maurel F2, Rudge H3
Affiliations: 1 University of Padova, Padova, Italy 2 IMS Health, Paris, France 3 GlaxoSmithKline, Uxbridge, UK
Publications: 
ISPOR 13th Annula European Congress to be held 6-9 November 2010 at the Prague Congress Centre in Prague, Czech Republic
Document Types: , Abstract, Poster
Countries: , Canada, Germany, UK, USA
Condition Year Language Analysis type
, Dermatology 2010 English , Literature Review
 
 
The Economic Impact of Overactive Bladder Syndrome in Six Western Countries.
Authors: Irwin DE1, Mungapen L2, Milsom I3, Kopp Z4, Reeves P2, Kelleher C5
Affiliations: 1Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, NC, US 2 IMS Health incorporating Fourth Hurdle Consulting Ltd, London, UK 3 Department of Obstetrics & Gynaecology, Sahlgrenska Academy at the University of Gothenburg, Sweden 4 Pfizer Inc., New York, USA, , 5 Department of Obstetrics and Gynaecology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
Publications: 
British Journal of Urology International (BJU International), 103(2):202-209
Document Types: , Article
Countries: , Canada, Germany, Italy, Spain, Sweden, UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19278532?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=1
Condition Year Language Analysis type
, Overactive bladder 2009 English , Budget impact
 
 
Health economic comparison between continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) of insulin for the treatment of adult type 1 diabetes in Canada.
Authors: St. Charles M1, Sadri H2, Minshall M1, Tunis S3
Affiliations: 1 Formerly of IMS Health, Indianapolis, IN, US 2 Medtronic Canada Ontario 3 IMS Health, Indianapolis, IN, US
Publications: 
Clinical Therapeutics, 2009, 31(3): 657-67
Document Types: , Manuscript in preparation
Countries: , Canada
Abstract: http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VRS-4W4CMKG-N&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=bbc2be5b77a418d332505b1ea4e93261
Condition Year Language Analysis type
, Diabetes 2009 English , Cost effectiveness
 
 
Cost-effectiveness of insulin analogues for diabetes mellitus
Authors: Cameron C1, Bennett H1
Affiliations: 1 Canadian Agency for Drugs and Technologies in Health, Ottawa, Canada
Publications: 
Canadian Medical Association Journal, 2009, 180(4): 400-407
Document Types: , Article
Countries: , Canada
Abstract: http://www.cmaj.ca/cgi/content/full/180/4/400
Condition Year Language Analysis type
, Diabetes 2009 English , Cost effectiveness
 
 
A Globally Optimal k-Anonymity Method for the De-identification of Health Data.
Authors: KHALED EL EMAM, PHD, FIDA KAMAL DANKAR, PHD, ROMEO ISSA, MS, ELIZABETH JONKER, BA, DANIEL AMYOT, PHD, ELISE COGO, ND, JEAN-PIERRE CORRIVEAU, PHD, MARK WALKER, MS, MD, SADRUL CHOWDHURY, MS, REGIS VAILLANCOURT, BPHARM, PHARMD, TYSON ROFFEY, BA, JIM BOTTOMLEY, BSCH, MHA
Affiliations: Children’s Hospital of Eastern Ontario Research Institute (KEE, FKD, EJ, EC, RV, TR, JB), Ottawa, Ontario, Canada; Pediatrics, Faculty of Medicine (KEE), School of Information Technology and Engineering (DA, SC), University of Ottawa, Ottawa, Ontario, Canada; School of Computer Science (RI, J-PC), Carleton University, Ottawa, Ontario, Canada; Ottawa Hospital Research Institute (MW), Ottawa, Ontario, Canada.
Publications: 
Journal of the American Medical Informatics Association
Document Types: , Article
Countries: , Canada
Abstract: https://watermark.silverchair.com/jamia.m3144.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAh8wggIbBgkqhkiG9w0BBwagggIMMIICCAIBADCCAgEGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMV_JYq2YeyT3x7ZGGAgEQgIIB0m8zmdADRJniIyvyVCYC8USRD7o4BkEOoK4uF65LmDb24pXAbafplEsE8JYZFNlsfioGMd3VElD1BCSdQiMP3whzpkqiJKOY9QBvdmwATCq79TkYj0mYawUN3N7_8FJeJcBSX2QBw93JwWk3qsBmtdcrBx7JuUeIvEiqfKP_T_U5_7V61pveujmYMOG-7oaa5q3plG1aj_DIzsj84UOdvL_Tr1rsv0zOOJoSTtsUuDVz7vXHuIFhhXhgtzRkZ2BDJYU1dN9bjIumrVJLcEkVEJRyJqGL5arzFn5CyHnUMPwuU4xNMok8JS_fdYrJhRz_POHRHHITCk9lqy6xtfIZV8Q1X8LhlO3QAHgyl6yX3wkktjGEfB7KHop1heWnTV5jFo95UFO4s1CtN_CmhDQxv_I139JdablwNc8BCCqNVXgDGcix1HOFWccp1LWxnLO_D2loe7bZgb_oPeHxmazvNH_PP8PK_2NlfxRQ98FXGryUlm7A-Otjg_HZJb_2bMlEI07sLnI1n9x9YOHJT5ZqMTbgfROrqs8J7dxSG0j7GLoOB04_4tBWmBRhWP1HOwROwFuJDW9chF5spZfkEu0w26WV9UxFN0LssqYFhhrxgTXZWnQ
Condition Year Language Analysis type
, Methodology 2009 English , De-identification / anonymisation
 
 
Canadian cost utility analysis comparing exenatide versus insulin glargine in patients with type two diabetes
Authors: Coyle D, Coyle K, Valentine WJ, Lee JB, Kisswani R, Boye KS
Affiliations: 
Publications: 
ISPOR 2008 13th Annual International Congress
Document Types: , Poster
Countries: , Canada
Condition Year Language Analysis type
, Diabetes 2008 English , Cost utility
 
 
Gadofosveset in the management of peripheral arterial occlusive disease in Canada - a model approach focusing on diagnostic confidence
Authors: Hass B1, Rebeira M2, Lungershausen J1, Jaszewski B2, D`Onofrio F2, Kienbaum S3
Affiliations: 1 IMS Health, Nuremberg, Germany 2 Bayer HealthCare, Toronto, ON, Canada 3 Bayer Schering Pharma AG, Berlin, Germany
Publications: 
ISPOR 13th Annual International Congress, May 3-7, 2008, Toronto, Canada
ISPOR 13th Annual International Congress, May 3-7, 2008,Toronto, Canada
Value in Health, 2008, 11(3): A196
Document Types: , Abstract, Oral presentation, Poster
Countries: , Canada
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(10)70623-9/abstract
Condition Year Language Analysis type
, Cardiovascular disease, Vascular disease 2008 English , Cost benefit, Cost effectiveness
 
 
The cost-utility of aliskiren in the treatment of mild to moderate hypertension. A Canadian health care system perspective
Authors: Lee A, Barry SJ, Leiter L, Nanji A, Annemans L, Tucker D, Michaliszyn AF, Barbeau M, Vincze G
Affiliations: 
Publications: 
ISPOR 13th Annual International Meeting, 2008, May 3-7, Toronto, Canada
Document Types: , Poster
Countries: , Canada
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(10)70642-2/abstract
Condition Year Language Analysis type
, Cardiovascular disease 2008 English , Cost utility
 
 
Cost-Effectiveness of Insulin Detemir Compared to NPH Insulin for Type 1 (T1DM) and Type 2 Diabetes Mellitus (T2DM) in the Canadian Payer Setting: modeling analysis
Authors: Tunis S1, Minshall M2, Conner C, McCormick J, Kapor J, Yale J, Groleau D
Affiliations: 1 IMS Health, Falls Church, VA, US 2 Formerly of IMS Health, Falls Church, VA, US
Publications: 
Current Medical Research and Opinion, 2009, 25(5): 1273-84
Document Types: , Manuscript in preparation, Poster
Countries: , Canada
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/19366302
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Cost-effectiveness of Insulin Detemir Compared to NPH Insulin for Type 1 Diabetes mellitus (T1DM) in the Canadian Payer Setting: Modeling Analysis using a Randomized Controlled Trial.
Authors: Minshall ME1, Tunis SL2, Conner C, McCormick JI, Kapor J, Groleau D
Affiliations: 1 Formerly of IMS Health, Falls Church, VA, USA IMS Health, Falls Church, VA, USA
Publications: 
ISPOR 2008 13th Annual International Congress
Value in Health, 2008; 11(3):A223-A224.
Document Types: , Manuscript in preparation, Poster
Countries: , Canada
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Cost-Effectiveness of Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Hip Replacement in Canada
Authors: Diamantopoulos A1, Forster F1, Lees M2, McDonald HP3
Affiliations: 1 IMS Health, London, UK, 2 Bayer HealthCare, Uxbridge, UK, 3 Bayer Inc, Toronto, ON, Canada
Publications: 
ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece
Thrombosis and haemostasis, 2010, 104(4): 760-70
Document Types: , Poster
Countries: , Canada
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/20806107
Condition Year Language Analysis type
, Musculoskeletal disease 2008 English , Cost effectiveness
 
 
Prevalence of opioid dispensings and concurrent gastrointestinal medications in Quebec
Authors: Williams RE1, Bosnic N2, Sweeney CT3, Duncan AW3, Levine KB4, Brogan M2, Cook SF3
Affiliations: 1 Worldwide Epidemiology, GlaxoSmithKline, Collegeville, Pennsylvania, USA 2 Brogan Inc, Ottawa, Ontario 3 Worldwide Epidemiology, GlaxoSmithKline, Research Triangle Park 4 Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Publications: 
Pain Research & Management, 2008, 13(5): 395–400.
Document Types: , Abstract
Countries: , Canada
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2799263/
Condition Year Language Analysis type
, Gastrointestinal disorders, Pain 2008 English , Retrospective cohort analysis
 
 
Prevalence of opioid dispensings and concurrent gastrointestinal medications in an elderly population from Ontario, Canada
Authors: Williams R1, Bosnic N, Duncan AW, Brogan M, Cook SF
Affiliations: 1 GlaxoSmithKline, Worldwide Epidemiology, Research Triangle Park, North Carolina, USA
Publications: 
Journal of Opioid Management, 2008, 4(4): 193-200
Document Types: , Abstract
Countries: , Canada
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/18837202
Condition Year Language Analysis type
, Gastrointestinal disorders, Pain 2008 English , Retrospective cohort analysis
 
 
Cost-Effectiveness of Insulin Detemir Compared to NPH Insulin for Type 2 Diabetes Mellitus (T2DM) in the Canadian Payer Setting: Modeling Analysis using an Observational Study
Authors: Minshall ME1, Tunis SL2, Conner C, McCormick JI, Kapor J, Groleau D
Affiliations: 1 Formerly of IMS Health, Falls Church, VA, USA IMS Health, Falls Church, VA, USA
Publications: 
ISPOR 2008 13th Annual International Congress
Document Types: , Poster
Countries: , Canada
Condition Year Language Analysis type
, Diabetes 2008 English , Observational study
 
 
SMBG Cost-Effectiveness in Canada
Authors: Minshall M1, Tunis SL2, Tuttle, J, Ur E
Affiliations: 1 Formerly of IMS Health, Falls Church, VA, US 2 IMS Health, Falls Church, VA, US
Publications: 
Canadian Diabetes Association Professional Conference, Vancouver, October 24-27, 2007
Document Types: , Abstract
Countries: , Canada
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Cost-utility analysis of rituximab as a new therapeutic option for rheumatoid arthritis patients in Canada
Authors: Mistry B1, McCormick J2, Diamantopoulos A3, Kielhorn A4
Affiliations: 1 Hoffmann-La Roche Ltd, Mississauga, ON, Canada, 2McKesson Phase 4 Solutions, Toronto, ON, Canada, 3M-TAG UK Ltd, London, UK, 4F. Hoffmann-La Roche Ltd, Basel, Switzerland
Publications: 
ISPOR 9th Annual European Congress. Copenhagen, Denmark
Value in Health, 2006, 9(6): A222
Document Types: , Abstract, Poster
Countries: , Canada
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(10)63265-2/abstract
Condition Year Language Analysis type
, Rheumatology 2006 English , Cost utility
 
 
Copyright 2024 IMS Health Incorporated. All rights reserved.